Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 8, 2009, Pages 1307-1312

  Theeten, Heidi ^a   Vandermeulen, Corinne ^b   Roelants, Mathieu ^b   Hoppenbrouwers, Karel ^b   Depoorter, Anne Marie ^c   Van Damme, Pierre ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Belgium; Children; Immunization; Vaccination age; Vaccination coverage

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

AGE DISTRIBUTION; ARTICLE; BELGIUM; CHILD; DIPHTHERIA; FEMALE; HEALTH CARE DELIVERY; HEPATITIS B; HUMAN; INFECTION PREVENTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEASLES; MEDICAL RECORD; MENINGOCOCCOSIS; MUMPS; PARENT; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RUBELLA; SCHOOL CHILD; SCHOOL HEALTH SERVICE; SOCIAL STATUS; TETANUS; VACCINATION;

BELGIUM; CHILD; CLUSTER ANALYSIS; CONFIDENCE INTERVALS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MENINGOCOCCAL VACCINES; PATIENT COMPLIANCE; POLIOVIRUS VACCINES; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 68249097415     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01331.x     Document Type: Article

References (21)

1. Salmaso S, Rota MC, Ciofi Degli Atti ML, Tozzi AE, Kreidl P. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. Bull World Health Organ 1999 77 : 843 51.
2. Tickner S, Leman PJ, Woodcock A. Factors underlying suboptimal childhood immunisation. Vaccine 2006 24 : 7030 6.
3. Vellinga A, Depoorter AM, Van Damme P. Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. Acta Paediatr 2002 91 : 599 603. (Pubitemid 34620650)
4. Swennen B, Van Damme P, Vellinga A, Coppieters Y, Depoorter AM. Analysis of factors influencing vaccine uptake: perspectives from Belgium. Vaccine 2001 20 : S5 7.
5. Van Damme P, Lernout T, Swennen B, Theeten H. VENICE country profile of Belgium. V&I News, Bi-weekly Newsletter on Vaccines and Immunization 2006 12 : 1 2.
6. World Health Organisation doIVaB. Immunization Coverage Cluster Survey- Reference Manual (WHO /IVB/04.23). 2005 ed. WHO Document Production Services, Geneva, Switzerland, 2005.
7. Theeten H, Hens N, Vandermeulen C, Depoorter AM, Roelants M, Aerts M, et al. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey. Vaccine 2007 25 : 4940 8.
8. Vandermeulen C, Roelants M, Theeten H, Depoorter AM, Van Damme P, Hoppenbrouwers K. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics 2008 121 : E428 34.
9. Vandermeulen C, Roelants M, Theeten H, Van Damme P, Hoppenbrouwers K. Vaccination coverage and sociodemographic determinants of measles-mumps-rubella vaccination in three different age groups. Eur J Pediatr 2008 167 : 1161 8.
10. Lumley T. Analysis of complex survey samples. JSS 2004 9.
11. COVER programme: January to March 2005 CDR Weekly 2008 15. Available at : http://www.hpa.org.uk/cdr/archives/back-issues.htm (accessed November 15, 2008)
12. Poethko-Müller C, Kuhnert R, Schlaud M. Durchimpfung und Determinanten des Impfstatus in Deutschland. Bundesgesundheitsblad 2007 50 : 851 62.
13. Abbink F, Oomen PJ, Zwakhals SLN, de Melker HE, Ambler-Huiskes A. Immunization coverage in the Netherlands as at 1 Januari 2005. RIVM rapport 2100210054 Bilthoven, the Netherlands: National Institute for Public Health and the Environment, 2006 : 16.
14. Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005-2010. ISBN 92 890 1382 6 Copenhagen, Denmark : WHO Regional Office for Europe, 2006.
15. Van Der Wal MF, Diepenmaat ACM, Pel JM, Hirasing RA. Vaccination rates in a multicultural population. Arch Dis Child 2005 90 : 36 40. (Pubitemid 40052250)
16. Miller E, Salisbury D, Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2001 20 : S58 67.
17. Welte R, Van Den DG, Bos JM, de Melker H, van Alphen L, Spanjaard L, et al. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine 2004 23 : 470 9.
18. De Schrijver K, Maes I. An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002. Eur J Epidemiol 2003 18 : 1073 7.
19. Bonanni P, Bergamini M. Factors influencing vaccine uptake in Italy. Vaccine 2001 20 : S8 12.
20. Pearce A, Law C, Elliman D, Cole TJ, Bedford H. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. BMJ 2008 336 : 754 7.
21. Luman ET, McCauley MM, Shefer A, Chu SY. Maternal characteristics associated with vaccination of young children. Pediatrics 2003 111 : 1215 18.